Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

BackgroundHepatic arterial infusion chemotherapy (HAIC) is increasingly recognized as a primary treatment option for patients with unresectable hepatocellular carcinoma (uHCC), providing a focused treatment for localized tumors. The combination of lenvatinib, a multikinase inhibitor, with PD-1 inhib...

Full description

Saved in:
Bibliographic Details
Main Authors: Lingling Zhao, Cheng Xu, Jiewen Deng, Yang Ni
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
hepatic arterial infusion chemotherapy (HAIC)
hepatocellular carcinoma (HCC)
Lenvatinib
PD-1 inhibitors
meta-analysis
unresectable cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1513394/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items